Human Albumin Biotest

Human Albumin Biotest is a prescription‑only intravenous solution for injection that contains human serum albumin as its active ingredient. The product is supplied as a sterile liquid preparation, with the exact concentration of albumin not disclosed in the available labeling. Manufactured for the European market, this plasma‑derived protein is classified as a volume expander and is used to restore oncotic pressure in patients with low plasma volume.

Human Albumin Biotest is indicated for clinical situations where plasma volume expansion or albumin replacement is required.

- Treatment of hypovolemia resulting from blood loss, trauma, or dehydration. - Management of hypoalbuminemia associated with liver disease, nephrotic syndrome, or malnutrition. - Fluid resuscitation in severe burn injuries to support intravascular volume. - Supportive therapy for patients in shock or undergoing major surgery. - Replacement of albumin during extensive plasma exchange procedures.

Adverse reactions to Human Albumin Biotest may vary in frequency and severity.

Common: - Fever or chills during or after infusion. - Mild hypotension or transient blood pressure changes. - Localized rash or urticaria at the infusion site. - Headache or dizziness. - Nausea or mild gastrointestinal discomfort.

Serious: - Anaphylactic or severe allergic reactions. - Volume overload leading to pulmonary edema. - Acute kidney injury due to rapid fluid shifts. - Hemolysis or transfusion‑related acute lung injury. - Thrombotic events such as deep vein thrombosis. - Severe hypotension requiring medical intervention.

When using Human Albumin Biotest, clinicians should consider several safety measures.

- Assess for known hypersensitivity to human albumin or any product components. - Monitor fluid balance closely in patients with cardiac or renal insufficiency to avoid volume overload. - Use caution in individuals with severe hypervolemia or pulmonary edema. - Adjust dosing in neonates and pediatric patients based on weight and clinical response. - Evaluate electrolyte status before and during therapy, especially sodium and potassium levels. - Ensure proper aseptic technique to reduce the risk of infection during infusion.

Human Albumin Biotest may interact with other therapies, requiring careful management.

Avoid: - Concurrent administration of other volume expanders or colloids without medical supervision. - Simultaneous high‑dose diuretics that may exacerbate intravascular volume shifts. - Use with caution: - ACE inhibitors or ARBs, which can potentiate hypotensive effects. - Non‑steroidal anti‑inflammatory drugs (NSAIDs) that may affect renal perfusion. - Vasopressor agents, as albumin infusion can alter hemodynamic responses. - Other plasma‑derived products, due to potential additive immunologic risk.